Retatrutide: A New Era in Weight Loss, But What Are We Really Losing?
Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape
A Collective Sigh of Relief: Eli Lilly Breaks Nine-Day Losing Streak
The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?